Journal of Biomedical Engineering and Medical Devices
Open Access

Stem Cell Technology its Actions and Mechanisms in Disease Modeling and Biomedical Engineering

Morgan Christie^{* *}Correspondence: Morgan Christie, Department of Medicine, University of Michigan, Ann Arbor, Michigan, United States of America, Email:

Author info »

Description

The field of biomedical engineering is at the forefront of revolutionizing healthcare by merging principles of engineering and medicine to develop innovative solutions for diagnosing, treating, and preventing diseases. A key player in this realm is stem cell technology, which has garnered immense attention for its potential to reshape the landscape of regenerative medicine, drug discovery, and disease modeling. Stem cells possess the unique ability to differentiate into various cell types, making them a powerful tool in addressing a wide array of medical challenges.

A versatile resource

Stem cells are undifferentiated cells that have the remarkable capability to develop into different cell types and regenerate damaged tissues. They exist in various forms, including embryonic stem cells, Induced Pluripotent Stem Cells (iPSCs), and adult stem cells. Embryonic stem cells, derived from embryos, have the broadest differentiative potential. iPSCs, on the other hand, are generated from adult cells that are reprogrammed to a pluripotent state, resembling embryonic stem cells in their versatility. Adult stem cells are found in various tissues and play a crucial role in tissue maintenance and repair [1].

Regenerative medicine and tissue engineering

Stem cell technology holds immense promise in regenerative medicine, aiming to replace or restore damaged tissues and organs. Researchers are exploring ways to coax stem cells into differentiating into specific cell types to regenerate tissues such as heart muscle, nerve cells, and pancreatic islets. This approach has the potential to revolutionize treatments for conditions that were previously considered irreversible, such as spinal cord injuries, heart disease, and Parkinson's disease.

Tissue engineering, a subset of regenerative medicine, involves the development of artificial tissues using a combination of biomaterials, cells, and biochemical factors. Stem cells play a pivotal role in tissue engineering by providing a reliable cell source for constructing functional tissues outside the body. For instance, 3D-printing techniques combined with stem cells have been used to create functional organs-on-chips, which replicate the structure and function of human organs for drug testing and disease modelling [2].

Drug discovery and disease modeling

Stem cell technology has transformed the landscape of drug discovery by providing more relevant and predictive cellular models for testing potential therapies. Traditional drug testing methods rely on animal models that may not accurately reflect human physiology. Stem cell-derived models, on the other hand, offer a more human-centric approach. Researchers can generate specific cell types affected by a disease, such as neurons in the case of neurodegenerative disorders, and screen potential drugs for efficacy and safety. This accelerates the drug development process and reduces the need for animal testing.

Moreover, stem cell technology enables the creation of disease models that mimic the progression of various disorders, allowing researchers to study disease mechanisms and test potential interventions. These models have been instrumental in advancing and understanding of conditions like Alzheimer's disease, diabetes, and inherited genetic disorders [3].

Challenges and ethical considerations

While stem cell technology holds tremendous promise, it also faces challenges and ethical considerations. The use of embryonic stem cells raises ethical debates due to the destruction of embryos during their extraction. However, the development of iPSCs has circumvented some of these concerns by offering a source of pluripotent cells without embryo destruction.

Another challenge lies in ensuring the safety and efficacy of stem cell therapies. Controlling the differentiation of stem cells into desired cell types and preventing the formation of tumors remains a significant hurdle. Rigorous testing, standardization of protocols, and advancements in cell culture techniques are critical in addressing these challenges [4].

Conclusion

Stem cell technology continues to reshape the landscape of biomedical engineering, offering unprecedented opportunities in regenerative medicine, drug discovery, and disease modeling. The ability to harness the potential of stem cells to differentiate into diverse cell types has unlocked new avenues for treating previously incurable diseases and advancing an understanding of human physiology. As research in this field progresses, it is essential to strike a balance between innovation, ethics, and patient safety to fully realize the potential of stem cell technology in revolutionizing healthcare.

References

1. Sacchetti B, Funari A, Remoli C, Giannicola G, Kogler G, Liedtke S, et al. No identical “mesenchymal stem cells” at different times and sites: human committed progenitors of distinct origin and differentiation potential are incorporated as adventitial cells in microvessels. Stem cell reports. 2016;6(6):897-913.

   [Crossref] [Google Scholar] [PubMed]

2. Sacchetti B, Funari A, Michienzi S, Di Cesare S, Piersanti S, Saggio I, et al. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell. 2007;131(2):324-336.

   [Crossref] [Google Scholar] [PubMed]

3. Molè MA, Weberling A, Zernicka-Goetz M. Comparative analysis of human and mouse development: From zygote to pre-gastrulation. Curr Top Dev Biol. 2020;136:113-138.

   [Crossref] [Google Scholar] [PubMed]

4. Niakan KK, Eggan K. Analysis of human embryos from zygote to blastocyst reveals distinct gene expression patterns relative to the mouse. Dev Biol. 2013;375(1):54-64.

   [Crossref] [Google Scholar] [PubMed]

5. Allison TF, Smith AJ, Anastassiadis K, Sloane-Stanley J, Biga V, Stavish D, et al. Identification and single-cell functional characterization of an endodermally biased pluripotent substate in human embryonic stem cells. Stem cell reports. 2018 Jun 5;10(6):1895-1907.

   [Crossref] [Google Scholar] [PubMed]